Janux Therapeutics Inc (NASDAQ: JANX) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Janux Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $14.61 and fluctuated between $15.87 as its day high and $13.20 as its day low. The current market capitalization of Janux Therapeutics Inc is $674.54M. A total of 0.64 million shares were traded on the day, compared to an average of 112.26K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, JANX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 4 BUYs and 0 SELLs from insiders. Insiders purchased 3,044,570 shares during that period but sold 0.

In the most recent transaction, Reardon Tighe bought 849,854 shares of JANX for 5.87 per share on Nov 13. After the transaction, the Acting Chief Financial Officer now owns 849,854 company shares. In a previous transaction on Nov 13, Lichter Jay bought 849,854 shares at 5.87 per share. JANX shares that Director owns now total 849,854.

Among the insiders who bought shares, Avalon Ventures XI, L.P. acquired of 849,854 shares on Nov 13 at a per-share price of $5.87. This resulted in the 10% Owner holding 849,854 shares of JANX after the transaction. In another insider transaction, RA CAPITAL MANAGEMENT, L.P. bought 495,008 shares at $12.46 per share on Jul 19. Company shares held by the Director now total 8,117,246.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for JANX in the last 3 months, the mean price target is $26.67 with high estimates of $35.00 and low estimates of $21.00. In terms of 52-week highs and lows, JANX has a high of $18.28 and a low of $5.65.

As of this writing, JANX has an earnings estimate of -$0.41 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.3 per share and a lower estimate of -$0.49. The company reported an EPS of -$0.42 in the last quarter, which was 19.20% higher than expectations of -$0.52.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. JANX’s latest balance sheet shows that the firm has $374.96M in Cash & Short Term Investments as of fiscal 2021. There were $194.00k in debt and $12.80M in liabilities at the time. Its Book Value Per Share was $7.56, while its Total Shareholder’s Equity was $366.33M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JANX is Buy with a score of 5.00.

Most Popular

Related Posts